scholarly article | Q13442814 |
P356 | DOI | 10.1038/BJC.1991.263 |
P953 | full work available at URL | http://www.nature.com/articles/bjc1991263 |
http://www.nature.com/articles/bjc1991263.pdf | ||
https://europepmc.org/articles/PMC1977331 | ||
https://europepmc.org/articles/PMC1977331?pdf=render | ||
P932 | PMC publication ID | 1977331 |
P698 | PubMed publication ID | 1854617 |
P5875 | ResearchGate publication ID | 21300601 |
P2093 | author name string | A. W. Craft | |
A. D. Pearson | |||
J. M. Chessells | |||
S. Mills | |||
D. R. Long | |||
H. A. Amineddine | |||
M. Yule | |||
P2860 | cites work | Dose-response effect of adjuvant chemotherapy in breast cancer | Q28283048 |
Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia | Q34513265 | ||
Polyglutamation of methotrexate. Is methotrexate a prodrug? | Q34552178 | ||
Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia | Q35603604 | ||
Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia | Q36044389 | ||
The importance of dose intensity in chemotherapy of metastatic breast cancer | Q40190080 | ||
Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia | Q40624289 | ||
Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis | Q41762709 | ||
Drug dosage and remission duration in childhood lymphocytic leukemia | Q44949634 | ||
A reliable method for evaluating drug compliance in children with cancer | Q46215445 | ||
Pharmacokinetics of oral methotrexate in children. | Q51647048 | ||
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia | Q68092294 | ||
Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia | Q68202669 | ||
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect | Q68719349 | ||
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy | Q71248649 | ||
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia | Q72571805 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
oncology | Q162555 | ||
methotrexate | Q422232 | ||
P304 | page(s) | 169-173 | |
P577 | publication date | 1991-07-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia | |
P478 | volume | 64 |
Q40791634 | An odyssey in search of a cure: the evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom. |
Q40736715 | Biology and treatment of acute lymphoblastic leukemia |
Q41532868 | Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies? |
Q56391087 | Dose calculation of anticancer drugs |
Q37098221 | Induction of acute lymphocytic leukemia differentiation by maintenance therapy |
Q34797124 | Maintenance treatment and shared care in lymphoblastic leukaemia |
Q27023839 | Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction |
Q44272964 | Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis |
Q73514183 | On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia |
Q42689021 | Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia |
Q52384093 | Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma. |
Q77761715 | Practical treatment guide for dose individualisation in cancer chemotherapy |
Q71041217 | Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study |
Q73596981 | Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables |